Loading...
In late April, Takeda Pharmaceuticals will begin marketing its proton pump inhibitor Kapidex (dexlansoprazole) under the new name Dexilant, owing to dispensing errors that have occurred from mix-ups with the prostate cancer drug Casodex (bicalutamide) and the analgesic Kadian (morphine).
Comment
LINK(S):
FDA news release (Free)